# D-cycloserine in the Management of Chemotherapy-Induced Peripheral Neuropathic Pain

> **NCT00301080** · PHASE3 · TERMINATED · sponsor: **Northwestern University** · enrollment: 7 (actual)

## Conditions studied

- Neurotoxicity
- Pain
- Breast Cancer

## Interventions

- **DRUG:** D-cycloserine
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00301080
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-02
- **Primary completion:** 2007-02
- **Final completion:** 2008-05
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Funding for the study fell through.
- **Last updated:** 2013-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00301080

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00301080, "D-cycloserine in the Management of Chemotherapy-Induced Peripheral Neuropathic Pain". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00301080. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*